Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab therapeutic drug monitoring in severe sarcoidosis
NL-OMON29326Recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Jan 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of infliximab in sarcoidosis, sponsored by St. Antonius Ziekenhuis. Primary endpoint: Comparison of responders versus non-responders by infliximab immunogenicity and exposure. Started Jan 2011; status: recruiting.
02
Drugs
infliximab
03
Conditions
sarcoidosis
Beyond the preview
Go deeper on NL-OMON29326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29326.